Hikma receives FDA approval for its generic Vascepa®
Go back to Hikma receives FDA approval for its generic Vascepa®| Hikma Pharmaceuticals plc, London (AMEX: HKMPF) | Delayed: 22.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.19 | 52 Week High | $35.25 | |||
| Open | $22.19 | 52 Week Low | $20.50 | |||
| Day High | $22.19 | P/E | N/A | |||
| Day Low | $22.19 | EPS | $0.00 | |||
| Volume | 17 | |||||
| Hikma Pharmaceuticals plc, London Sponsored ADR (AMEX: HKMPY) | Delayed: 43.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.18 | 52 Week High | $76.47 | |||
| Open | $43.18 | 52 Week Low | $50.73 | |||
| Day High | $43.18 | P/E | N/A | |||
| Day Low | $43.18 | EPS | $0.00 | |||
| Volume | 490 | |||||
